Validation of the French Version of the QASCI in Caregivers of Patients With COPD

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Brest

About this trial

This study aims to validate the French version of the QASCI questionnaire, initially written and validated in Portuguese language by Hipolito et al., to assess caregiving burden in chronic obstructive pulmonary disease (COPD).

The realization of this validation is significant on several levels. First, since COPD is a systemic condition, it affects not only the lungs but also many other organs and systems in the body. It leads to various complications that go beyond respiratory symptoms, creating major challenges not only physically but also in terms of participation and involvement for patients and their caregivers. The lack of validated tools in French to specifically assess the quality of life of caregivers in this context represents a gap that this study seeks to fill.

This study is also justified by the fact that, although the QASCI has been validated in other languages and contexts, it is essential to linguistically and culturally adapt this tool for the French-speaking population. Validation in French is crucial to ensure the fidelity of the results obtained and the validity of the conclusions drawn from this instrument for caregivers of patients with COPD in France.

In summary, this study addresses a specific need by contributing to the prevention of pathologies among caregivers. It enhances early detection and support for caregivers of patients with COPD while paving the way for future research on this often-overlooked population.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Being a caregiver of a relative with COPD (according to the GOLD criteria).

Being 18 years old or older.

The patient under the caregiver's care must be in stable condition (no exacerbations in the previous month).

Being a family member of the patient or living with the patient.

Disqualifiers

None

Trial population

Informal caregivers of patients with COPD

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • questionnaire

    Other intervention

    Caregivers must reply to the French version of the QASCI questionnaire, the ZBI (Zarit Burden Interview) questionnaire, HADS (Hospital Anxiety and Depression Scale), and WHOQOL-Bref (World Health Organization Quality of Life Instrument - Short Form). After 15 days, they wil reply to the French version of the QASCI questionnaire (to asse the reliability).

Treatment groups

224 Participants
are divided into 1 treatment group
Group A: caregivers of patients with COPD1 intervention

Trial outcomes

Primary outcomes

1

Validation of the translation of the long version of the QASCI questionnaire (measuring caregiver burden) from Portuguese to French after the translation-back translation stage.

Responses to the QASCI questionnaire (32 items rated from 1 to 5 leading to an overall score and 7 subscores) and comparison with responses to the ZBI (Zarit Burden Interview), HADS (Hospital Anxiety and Depression Scale), and WHOQOL-Bref (World Health Organization Quality of Life Instrument - Short Form).

Time frame
baseline

Secondary outcomes

1

Assess the reliability of the translation of the long version of the QASCI questionnaire.

Responses to the QASCI questionnaire (32 items rated from 1 to 5 leading to an overall score and 7 subscores) at Day 0 and Day 15

Time frame
baseline and at day 15

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University Hospital, Brest

Lead sponsor

Centre Hospitalier des Pays de Morlaix

Collaborator